Cara Therapeutic
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $2,556 | $991 | $2,135 | $3,004 |
Gross Profit | 2,556 | 991 | 1,473 | 2,314 |
EBITDA | -10,443 | -18,029 | -28,672 | -31,651 |
EBIT | -10,516 | -18,106 | -28,714 | -31,733 |
Net Income | -12,476 | -20,016 | -30,696 | -32,337 |
Net Change In Cash | 2,556 | 991 | 2,135 | 3,004 |
Free Cash Flow | -13,984 | -12,647 | -31,289 | -19,422 |
Cash | 37,061 | 49,239 | 46,996 | 52,183 |
Basic Shares | 54,843 | 54,724 | 54,588 | 54,477 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $20,968 | $41,867 | $23,028 | $135,082 |
Gross Profit | 14,794 | 34,601 | 23,028 | 28,012 |
EBITDA | -117,650 | -87,287 | -88,835 | 5,594 |
EBIT | -117,909 | -87,535 | -89,083 | 4,579 |
Net Income | -118,513 | -83,413 | -88,193 | 8,410 |
Net Change In Cash | 20,968 | 41,867 | 23,028 | 135,082 |
Cost of Revenue | 50,288 | -18,230 | 13,378 | |
Free Cash Flow | -94,453 | -78,773 | -60,126 | -5,836 |
Cash | 51,775 | 63,741 | 13,453 | 31,683 |
Basic Shares | 54,149 | 53,653 | 50,718 | 47,915 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.11 |
2024-06-30 | -$0.37 |
2024-03-31 | -$0.56 |
2023-12-31 | -$0.59 |
